Posts in category: Uncategorized

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of low-dose apixaban, experienced similar VTE recurrences and less bleeding as similar patients who received a full dose of the oral blood-thinning medication over the same extended period. These findings from the API-CAT trial were presented at the American College of Cardiology’s Annual Scientific Session (ACC.25).

People who most frequently encounter everyday discrimination—those subtle snubs and slights of everyday life—are more likely to suffer from anxiety and depression.

A recent study conducted across nine Iowa hospitals has shown promising results in reducing postoperative opioid prescriptions by implementing Enhanced Recovery After Surgery (ERAS) pathways. The paper is published in the Journal of the American Academy of Orthopaedic Surgeons.

Scientists have revealed exactly how tobacco smoke damages DNA to drive the development of different types of head and neck cancer, a finding that could unlock new treatments and prevention strategies.

Researchers have developed a virtual reality-based system that shows promise in improving the differentiation between common mental health conditions, potentially paving the way for earlier and more personalized treatment. The work is published in the March edition of the journal European Neuropsychopharmacology, with a subsequent comment also being published in the same journal.

Pregnant women can be reassured that quit-smoking medicines such as nicotine patches and varenicline do not increase the risk of major birth defects in babies, according to new research from the National Drug and Alcohol Research Center (NDARC), UNSW Sydney.

April 1 marks National Caregivers Day in Canada. The day is meant to recognize the caregivers who provide vital care and support to those in need.

Loss of smell. It was a common symptom for millions of people during the COVID-19 pandemic.

In patients experiencing excessive bleeding during cardiac surgery, a concentrated blood product containing proteins that help the blood clot was significantly more effective and caused fewer adverse effects than frozen plasma, the standard therapy, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25). The concentrated product, known as four-factor prothrombin complex concentrate (4F-PCC), reduced patients’ risk of experiencing a major bleeding event by close to half compared with standard treatment.

Among iron-deficient patients with heart failure with reduced ejection fraction (HFrEF), receiving intravenous iron supplementation was found to be safe but resulted in mixed findings, according to a study presented at the American College of Cardiology’s Annual Scientific Session (ACC.25).